Role of OMT in the Management of the Persistent Post-COVID-19 Symptoms
ROMPS
1 other identifier
observational
7
1 country
1
Brief Summary
The goal of this observational study is to determine the feasibility of conducting a large-scale study on the effect of using osteopathic manipulative treatment (OMT) to treat patients with post-COVID-19 symptoms. The main questions it aims to answer are:
- 1.Is it feasible to conduct a large-scale study of the effect of OMT on patients with post-COVID-19 symptoms (based on how many patients agree to participate and how many complete the study)?
- 2.How much change in patients' post-COVID-19 symptom severity, quality of life, and ability to return to work can we expect to see following OMT?
- 3.Participants will complete questionnaires about their post-COVID-19 symptoms, quality of life, ability to return to work, and adverse events they experienced 3 days after every other OMT session.
- 4.Participants will be sent links to the questionnaires for 4 months or when their symptoms resolve, whichever comes first.
- 5.Additionally, participants will complete a follow-up questionnaire 2 months after they stop receiving OMT for their post-COVID-19 symptoms or 6 months after enrollment in the study, whichever comes first.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2023
CompletedFirst Posted
Study publicly available on registry
August 29, 2023
CompletedStudy Start
First participant enrolled
September 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2024
CompletedJuly 30, 2024
July 1, 2024
10 months
August 23, 2023
July 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient recruitment rate (feasibility)
Proportion of patients who enroll in the study out of the number of patients who were eligible for and invited to enroll in the study.
Through study completion, an average of 1 year
Data completion rate (feasibility)
Proportions of participants and physicians who complete all their questionnaires.
Through study completion, an average of 1 year
Secondary Outcomes (4)
Neurocognitive and psychological symptoms
3 days after every other OMT session for up to 4 months after enrollment and 2 months after the participant's final OMT session
Physical symptoms
3 days after every other OMT session for up to 4 months after enrollment and 2 months after the participant's final OMT session
Global health
3 days after every other OMT session for up to 4 months after enrollment and 2 months after the participant's final OMT session
Return to work
3 days after every other OMT session for up to 4 months after enrollment and 2 months after the participant's final OMT session
Other Outcomes (1)
Severity of potential adverse events from OMT
3 days after every other OMT session for up to 4 months after enrollment
Interventions
Osteopathic manipulative treatment provided at the discretion of the treating physician and based on the patient's response to previous treatments.
Eligibility Criteria
Patients of clinics in the United States where members of the practice-based research network, DO-Touch.NET, practice osteopathic manipulative treatment.
You may qualify if:
- at least one symptom of post-COVID-19 (eg, fatigue, dyspnea, anosmia, arthralgia, headache, sleep disturbances, anxiety/depression, or other problems related to mental health) which was new after diagnosis with COVID-19 and has persisted for at least 4 weeks after diagnosis
You may not qualify if:
- unable to speak, read, and write in English
- not mentally competent to give informed consent
- inability to complete surveys/questionnaires online
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Osteopathic Manipulative Medicine Gutensohn Clinic
Kirksville, Missouri, 63501, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian F Degenhardt, DO
A.T. Still University of Health Sciences
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 23, 2023
First Posted
August 29, 2023
Study Start
September 18, 2023
Primary Completion
July 10, 2024
Study Completion
July 10, 2024
Last Updated
July 30, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share